SNCA and supranuclear palsy, progressive, 1: Although o-α-synuclein and p-tau181 are closely involved in the physiopathology of PD and PSP, respectively, our study suggests that the serum concentrations of these proteins are not useful biomarkers to distinguish patient groups.